EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Prognostic values of molecular subtypes and SWI/SNF protein expression in de‐differentiated/undifferentiated endometrial carcinoma

Chae Young Shin, Bengul Gokbayrak iD, Valerie L Tao, Noorah Almadani, Eunice S Li, Rebecca Ho, Felix Kf Kommoss iD, Jutta Huvila iD, Derek Chiu iD, Samuel Leung iD, Basile Tessier-Cloutier iD, David G Huntsman iD and 4 more

Histopathology · 2025

DOI: 10.1111/his.15411 ↗

At a glance

Journal article in Histopathology, 2025. Written by Chae Young Shin and 15 co-authors. Institution: Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada. Major MEDLINE topics: Endometrial Neoplasms, Transcription Factors, Biomarkers, Tumor, Chromosomal Proteins, Non-Histone. Cited 8 times so far (Crossref); 32 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Faculty of Medicine, University of British Columbia, CIHR, Terry Fox Research Institute.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Aims

Classification and risk stratification of endometrial carcinoma (EC) has transitioned from histopathological features to molecular classification, e.g. the ProMisE classifier, identifying four prognostic subtypes: POLE mutant ( POLE mut) with almost no recurrence or disease‐specific death events, mismatch repair deficient (MMRd) and no specific molecular profile (NSMP), with intermediate outcome and p53 abnormal (p53abn) with poor outcomes. However, the applicability of molecular classification is unclear in rare but aggressive histotypes of EC, e.g. de‐differentiated and undifferentiated endometrial cancers (DD/UDEC). Here, we aim to assembled a cohort of DD/UDEC from a single institution and analysed the prognostic significance of ProMisE molecular subtypes and the expression of SWItch/sucrose non‐fermentable (SWI/SNF) chromatin remodelling complex members, previously implicated in the pathogenesis of DD/UDEC. Methods and results We accrued 88 DD/UDEC cases, assessed POLE status by Sanger sequencing and performed immunohistochemistry for p53, mismatch repair and SWI/SNF proteins on the tissue microarrays assembled. Assignment of molecular subtypes was possible in 80 tumours; POLE sequencing failed in the remaining eight cases. There were 12 (15%) POLE mut, 44 (55%) MMRd, 14 (17.5%) p53abn and 10 (12.5%) NSMP DD/UDEC. POLE mut DD/UDECs had excellent outcomes, but the other three molecular subtypes all had poor outcomes, with no significant differences among them. The loss of one or more SWI/SNF proteins [AT‐rich interactive domain‐containing protein 1A (ARID1A), ARID1B, SWI/SNF‐related, matrix‐associated, actin‐dependent regulator of chromatin, subfamily A, member 4 (SMARCA4), SMARCA2], observed in 66% (55 of 83) cases, was not of prognostic significance.

Conclusions

These results indicate that all molecular subtypes of DD/UDEC except POLE mut behave in an aggressive fashion. Further study is needed to determine whether these molecular alterations can be targeted with adjuvant therapy, in order to improve outcomes of patients with DD/UDEC.

Subjects

MeSH terms (MEDLINE)

Endometrial NeoplasmsTranscription FactorsBiomarkers, TumorChromosomal Proteins, Non-HistoneHumansFemalePrognosisMiddle AgedAgedAdultAged, 80 and overImmunohistochemistryDNA Polymerase IIDNA-Binding ProteinsDNA Mismatch RepairTumor Suppressor Protein p53Poly-ADP-Ribose Binding Proteins

Author keywords

POLESWI/SNFde‐differentiated endometrial carcinomamismatch repairmolecular subtypep53undifferentiated endometrial carcinoma

Substances

Transcription FactorsBiomarkers, TumorChromosomal Proteins, Non-HistoneDNA Polymerase IIPOLE protein, humanDNA-Binding ProteinsTumor Suppressor Protein p53Poly-ADP-Ribose Binding Proteins

Authors and institutions

  • Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Ovarian Cancer Research Centre, Vancouver Coastal Health Research Institute, Vancouver, British Columbia, Canada.
  • Department of Molecular Oncology, British Columbia Cancer Research Institute, Vancouver, British Columbia, Canada.
  • Department of Pathology, McGill University, Montreal, Quebec, Canada.
  • Genetic Pathology Evaluation Center, Vancouver General Hospital and University of British Columbia, Vancouver, British Columbia, Canada.
  • Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology, University of British Columbia and BC Cancer, Vancouver, British Columbia, Canada.

ORCID profiles: Bengul Gokbayrak, Felix Kf Kommoss, Jutta Huvila, Derek Chiu, Samuel Leung, Basile Tessier-Cloutier, David G Huntsman, C Blake Gilks, Jessica N McAlpine, Lynn Hoang, Yemin Wang

Funding

  • Faculty of Medicine, University of British Columbia
  • CIHR
  • Terry Fox Research Institute
  • Canadian Institutes of Health Research

Cite

APA

Shin, C. Y., Gokbayrak, B., Tao, V. L., Almadani, N., S Li, E., Ho, R., Kommoss, F. K., Huvila, J., Chiu, D., Leung, S., Tessier-Cloutier, B., Huntsman, D. G., Gilks, C. B., McAlpine, J. N., Hoang, L., & Wang, Y. (2025). Prognostic values of molecular subtypes and SWI/SNF protein expression in de‐differentiated/undifferentiated endometrial carcinoma. Histopathology. https://doi.org/10.1111/his.15411

Vancouver

Shin CY, Gokbayrak B, Tao VL, Almadani N, S Li E, Ho R, et al. Prognostic values of molecular subtypes and SWI/SNF protein expression in de‐differentiated/undifferentiated endometrial carcinoma. Histopathology. 2025. doi:10.1111/his.15411

BibTeX
@article{Shin2025,
  author = {Shin, Chae Young and Gokbayrak, Bengul and Tao, Valerie L and Almadani, Noorah and S Li, Eunice and Ho, Rebecca and Kommoss, Felix Kf and Huvila, Jutta and Chiu, Derek and Leung, Samuel and Tessier-Cloutier, Basile and Huntsman, David G and Gilks, C Blake and McAlpine, Jessica N and Hoang, Lynn and Wang, Yemin},
  title = {Prognostic values of molecular subtypes and SWI/SNF protein expression in de‐differentiated/undifferentiated endometrial carcinoma},
  journal = {Histopathology},
  year = {2025},
  doi = {10.1111/his.15411}
}
Start for free →